Y Combinator

Remedial Health is a company focused on enhancing access to medicines for healthcare retail businesses, including large pharmacies and small chemist shops. By utilizing advanced technology, it develops a pharmacy operations and procurement management platform that facilitates direct ordering from manufacturers and registered distributors. This platform supports both large and small retailers in streamlining their dispensing and workflow management processes, ensuring just-in-time stock availability. Additionally, Remedial Health provides financing options and a diverse selection of inventory, thereby improving the efficiency and effectiveness of medicine procurement for its clients.

Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.

Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.

Accelerating the discovery of immunotherapies

Pipe | bio builds bioinformatics solutions to help optimize development of antibodies and antibody-like-therapeutics.

Pipe | bio builds bioinformatics solutions to help optimize development of antibodies and antibody-like-therapeutics.

Atom Bioworks specializes in developing a pattern-recognition-enabled sensing and therapeutics platform aimed at enhancing medical applications for the early diagnosis and treatment of infectious diseases and cancer. The company's innovative platform leverages computational biology, quantum chemistry, software, and machine learning to identify diseased surface protein patterns. By creating corresponding pattern-matching constructs, Atom Bioworks provides researchers with advanced nano-pattern recognition capabilities, ultimately facilitating improved diagnostic and therapeutic strategies in the medical field.

H1 is the developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

Biocogniv Inc. specializes in developing artificial intelligence-powered diagnostic tools tailored for hospitals. Founded in 2019 and based in Burlington, Vermont, the company creates plugins for electronic health records (EHRs) that enhance clinical decision-making. Its initial product screens patients for COVID-19 by rapidly analyzing standard blood test results, achieving a sensitivity rate of 95%. Additionally, Biocogniv's technology aims to predict sepsis-related in-hospital mortality and the need for intensive care unit admission during emergency department visits. By seamlessly integrating with EHR workflows, Biocogniv's solutions facilitate accurate and non-invasive diagnostic methods, thereby improving patient outcomes and operational efficiency in the medical sector.

Biocogniv Inc. specializes in developing artificial intelligence-powered diagnostic tools tailored for hospitals. Founded in 2019 and based in Burlington, Vermont, the company creates plugins for electronic health records (EHRs) that enhance clinical decision-making. Its initial product screens patients for COVID-19 by rapidly analyzing standard blood test results, achieving a sensitivity rate of 95%. Additionally, Biocogniv's technology aims to predict sepsis-related in-hospital mortality and the need for intensive care unit admission during emergency department visits. By seamlessly integrating with EHR workflows, Biocogniv's solutions facilitate accurate and non-invasive diagnostic methods, thereby improving patient outcomes and operational efficiency in the medical sector.

Hannah Life Technologies Pte. Ltd., founded in 2019 and based in Singapore, specializes in designing and developing innovative devices aimed at improving conception chances for couples during intercourse. The company seeks to transform the infertility treatment landscape by creating groundbreaking and safe fertility products that address significant unmet needs in this field. Guided by a Scientific Advisory Board composed of leading fertility clinicians, Hannah Life Technologies is committed to advancing solutions that enhance reproductive health and support individuals facing infertility challenges.

Biobot Analytics is a wastewater epidemiology company that is transforming wastewater infrastructure into public health observatories. Its wastewater monitoring technology analyzes urine and stool samples to create a health database that is independent of hospital reporting systems, free from societal biases affecting who can and can’t seek care, and most importantly, rapidly adaptable to new and emerging public health threats.

H1 is the developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases. Felix Biotechnology's bio-therapeutics targets antibiotic-resistant bacteria to manage infectious diseases precisely and effectively, allowing healthcare professionals to manage urgent microbial challenges in human health.

Operator is building a low-code platform that makes it easy to build business applications. With Operator, analysts can build software solutions to common problems and bottlenecks without worrying about managing data or setting up integrations.

Culture Biosciences, founded in 2016 and headquartered in San Francisco, California, specializes in developing automated bioreactors and tools for fermentation. The company provides a digital bio-manufacturing platform that allows biotech companies to optimize their manufacturing processes, enabling them to bring products to market more efficiently. By utilizing robotic sample handling and cloud-based data monitoring and analysis, Culture Biosciences helps scientists run, monitor, and analyze bioreactors more quickly than traditional methods. This innovative approach supports the biotechnology sector in enhancing productivity and streamlining workflows.

H1 is the developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

RelianceHMO is a technology-driven health insurance company focused on providing affordable and reliable insurance solutions for the average African. The company aims to make health insurance more accessible by integrating telemedicine with data science, which helps streamline the process and reduce costs. Through its innovative approach, RelianceHMO addresses the challenges of the healthcare system in Africa, ensuring that more individuals can gain access to necessary medical services.

They've set out to modernize healthcare recruiting. They're a team of physicians and entrepreneurs who have come together to solve a major pain point facing medical professionals today. Healthcare is a noble profession that has become overburdened by loss of autonomy, administrative bloat, and an ever-increasing number of intermediaries widening the gap between patients and providers. They want to help realign the industry around its original purpose and let providers administer better care.

Hey Healthcare, Inc. develops automated medical billing software for therapists. Its software offers reporting, authorizations, benefit verifications, denial management, daily A/R work, and credentialing services. It helps to register therapists and invoice insurers and to gain insurance coverage claims for their offices. It also operates an online platform. It serves mental health care service providers and insurance companies. The company was founded in 2018 and is based in San Francisco, California.

Nettrons Inc. provides human resources and employment services to biotech and healthcare startups. Nettrons Inc. was incorporated in 2016 and is based in San Francisco, California.

Data Driven Bioscience is a company based in Durham, North Carolina, that specializes in providing integrated kits and software designed for cancer diagnosis. Their products enable clinical laboratories to utilize genomics in the diagnosis and treatment of cancer. The kits are equipped to connect with machine learning software and a comprehensive database of cancer cases, allowing for the generation of detailed molecular reports for individual tumors. This innovative approach aims to enhance the accuracy and effectiveness of cancer diagnostics, facilitating better treatment decisions for patients.

World's first stem cell marketplace - connecting willing donors with patients in need to help facilitate stem cell transplants

Tradewind BioScience is a biotechnology company developing antibody therapeutics for ovarian cancer. Tradewind BioScience is building tools to attack highly aggressive and deadly human cancers.

Culture Biosciences, founded in 2016 and headquartered in San Francisco, California, specializes in developing automated bioreactors and tools for fermentation. The company provides a digital bio-manufacturing platform that allows biotech companies to optimize their manufacturing processes, enabling them to bring products to market more efficiently. By utilizing robotic sample handling and cloud-based data monitoring and analysis, Culture Biosciences helps scientists run, monitor, and analyze bioreactors more quickly than traditional methods. This innovative approach supports the biotechnology sector in enhancing productivity and streamlining workflows.

BloomAPI strive to democratize access to healthcare data. To unlock a future where all EMRs are interoperable and where vendors can't hold data hostage for their competitive advantage. They are helping to make healthcare technology easier by connecting patients, providers, and payers.

RelianceHMO is a technology-driven health insurance company focused on providing affordable and reliable insurance solutions for the average African. The company aims to make health insurance more accessible by integrating telemedicine with data science, which helps streamline the process and reduce costs. Through its innovative approach, RelianceHMO addresses the challenges of the healthcare system in Africa, ensuring that more individuals can gain access to necessary medical services.

RelianceHMO is a technology-driven health insurance company focused on providing affordable and reliable insurance solutions for the average African. The company aims to make health insurance more accessible by integrating telemedicine with data science, which helps streamline the process and reduce costs. Through its innovative approach, RelianceHMO addresses the challenges of the healthcare system in Africa, ensuring that more individuals can gain access to necessary medical services.

MedTech is a professional community focused on advancing the bioscience and medical technology sectors. Founded in 2004 and based in Syracuse, New York, it provides platforms for professionals to connect, collaborate, and engage in education and advocacy. The organization hosts various events, including the MedTech Annual Conference and MedTech Annual Members' Dinner, which serve as networking and learning opportunities. Additionally, MedTech operates the MedTech Institute, offering training and certification programs aimed at enhancing skills within the industry. Through its comprehensive resources, including a dedicated website for news and updates, MedTech supports its members in navigating the evolving landscape of biotechnology and medical innovation.

Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacture of gene-modified cell therapies such as chimeric antigen receptor T cells. The technology is being developed with the help of the Australian National Fabrication Facility. We are alumni of NSW Health, IndieBio, Y Combinator and MBC Biolabs (née QB3@953). We are opening up an office in Sydney and have lab space at Bonneville Labs in Berkeley.

Nephrogen is a biotechnology company dedicated to developing novel diagnostics and research tools for various life threatening diseases.

CareRev operates a healthcare staffing marketplace that connects healthcare facilities with flexible clinical professionals. It provides an online platform that allows hospitals and outpatient facilities to directly access per diem medical staff without the involvement of vendors or agencies. This model enables healthcare facilities to fill empty shifts more rapidly, reduce overall staffing costs, and enhance the quality of patient care by maintaining safe nurse-to-patient ratios. CareRev's platform facilitates direct communication between facilities and healthcare professionals, giving the latter the freedom to choose their working hours and locations. The company is backed by Y Combinator and a group of notable business angels, focusing on addressing the significant staffing challenges within the healthcare sector.

Cryopreserving people's healthy young cells for use with future medical technologies.

At 20n, They use algorithms to engineer microbes. Specifically, their algorithms engineer microbes to make chemicals. Like yeast produces alcohol during beer brewing, their engineered microbes will produce chemicals with therapeutic health and industrial biotech applications. The best illustration of this DARPA-backed technology is the bacteria They engineered to produce Paracetamol (also known as acetaminophen, and sold under the brand name Tylenol). Aside from this bacteria, there is no known natural way of producing acetaminophen. They are building data mining technology that will allow us to enable the bioproduction of a whole spectrum of valuable molecules. Below is the map of every chemical that can be made biologically, as discovered by 20n's algorithms.

PicnicHealth is all about making medical records easy to access and using data to power the next frontier of medical research. We’re led by the belief that there’s power in medical information when it’s used well, and that every person has a right to their own theirs. And we've built award-winning machine learning to do it. How? PicnicHealth works directly with patients to give them the only tool anywhere that truly provides all of their medical records from any doctor or healthcare system in the US—in an easy-to-use, secure online dashboard. Not only that, but patients can choose to contribute their data to scientific research, which helps life sciences researchers accelerate breakthroughs in care. Researchers use this anonymized “real-world data” to understand how diseases are experienced by patients and treated by clinicians in the real world, going beyond the highly controlled setting of clinical trials. The goal is to create better treatments that can ultimately improve outcomes for patients. Whether you’re a scientist, engineer, or patient yourself, we’re looking for passionate people to join us in redefining an industry during our next stage of growth. To date we’ve helped tens of thousands of patients, partnered with some of the world’s largest biopharma companies, and raised more than $35M from Felicis Ventures, Amplify Partners, Foresite Capital, Refactor Capital, and Y Combinator.

Contagion Health (Jen McCabe) and Healthmonth (Buster Benson) merge to form Habit Labs.